Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 26 May 2020
Although the majority of women are having surgery in a specialist gynaecological oncology public hospital across NSW, women living in regional and remote areas were less likely to have their surgery in a specialist hospital.
Published date 22 May 2020
After adjusting for degree of spread, cancer type, and sociodemographic characteristics there was an increase in survival across the 1980-2015 study period for AYAs diagnosed with cancer.
Published date 01 May 2020
In predominantly fair-skinned populations, melanoma incidence appears to differ systematically and consistently between men and women by age and anatomic site.
Published date 01 April 2020
The estimated risk of progression of lentigo maligna to lentigo maligna melanoma was 3.5% per year.
Published date 19 March 2020
The health service and diagnostic pathway to diagnosis differs markedly for people notified with CUP compared to those with metastatic cancer of known primary.
Published date 16 March 2020
The needs of prostate cancer survivors could better be met with more coordinated approaches to multidisciplinary care and timely interventions and support for chronic sexual dysfunction.
Published date 10 March 2020
The capture of anticancer medicine use by the PBS was generally high but varied depending on cancer site. PBS data can be supplemented by MBS and inpatient data, to examine ‘fact of treatment’ with a very high capture.
Published date 21 February 2020
The incidence of colon and rectal cancers has continued to increase in countries with medium to high Human Development Index scores and in younger populations.
Published date 18 February 2020
Incidence and outcomes of neuroblastoma in Australian children: a population-based study (1983-2015)
Survival for childhood neuroblastoma has improved substantially over time in Australia, but still remains lower than for most other types of childhood cancer.
Published date 13 February 2020
The growing number of cancer survivors in Australia is likely to pose complex challenges for cancer patients, their care givers, and healthcare systems.
